Y0002276

Dipotassium clorazepate monohydrate

European Pharmacopoeia (EP) Reference Standard

• 동의어(들): Clorazepate dipotassium salt, 7-Chloro-2,3-dihydro-2,2-dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid
• Linear Formula: C₁₆H₁₁ClN₂O₄K₂
• CAS Number: 57109-90-7
• Molecular Weight: 408.92
• UNSPSC 코드: 41116107
• NACRES: NA.24

속성

• API family: clorazepate
• 제조업체/상표: EDQM
• 저장 온도: 2-8°C
• SMILES string: ClC1=CC=C2C(C(C3=CC=CC=C3)=NC(C(O[K])=O)C(N2)=O)=C1.[K]O
• InChI: 1S/C16H11ClN2O3.2K.H2O/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12;;;/h1-8,14H,(H,18,20)(H,21,22);;;1H2/q;2*+1;/p-2
• InChI key: QCHSEDTUUKDTIG-UHFFFAOYSA-L

설명

일반 설명

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

애플리케이션

Dipotassium clorazepate monohydrate EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

포장

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

기타 정보

Sales restrictions may apply.

안전성 정보

• 픽토그램: GHS08,GHS07
• 신호어: Warning
• 유해 및 위험 성명서: H302,H361
• 예방조치 성명서: P202 - P264 - P270 - P280 - P301 + P312 - P308 + P313
• Hazard Classifications: Acute Tox. 4 Oral - Repr. 2
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point (°F): Not applicable
• Flash Point (°C): Not applicable